# Informed Medical Decisions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/informed-medical-decisions

- Industry: Biotechnology
- Headquarters: St. Petersburg, US
- Website: www.informeddna.com
- Total disclosed funding: $61M
- Latest round: Series B (Dec 23, 2019)
- Investors on record: 4

## About

Based in Florida, US, and founded in 2007 by Chairman David Patrick Nixon and Chief Medical Officer Rebecca Sutphen, Informed Medical Decisions, Inc. operates as a provider of genomic insights and solutions, catering to payors, life sciences, and health systems. In September 2023, Informed Medical Decisions, Inc., a portfolio company of CIBC, CIBC Innovation Banking, Frist Cressey Ventures, MPM Capital, NovaQuest Capital Management, TT Capital Partners, and Zaffre Investments, acquired gWell, Inc.

Informed Medical Decisions, Inc. developed DNAimpact, which is a precision health platform that guides individuals in understanding their genetic health risks and provides personalized management options, including risk stratification, personalized screening protocols, education, testing, genetic counseling, and management recommendations. It provides genetic testing utilization management, this service ensures appropriate use of genetic tests through current medical policies, prior authorization, and decision support automation. The company offers payment integrity solutions, which is a customized prepay and post-pay solutions that ensure healthcare dollars are spent appropriately by preventing incorrect payments, minimizing appeals, and identifying overpayments. In addition, the firm provides genetic counseling solutions and clinical trial recruitment for supporting the healthcare and life science industries.

## Funding rounds

- Series B, Dec 23, 2019, $50M — TT Capital Partners, Frist Cressey Ventures, QHP Capital
- Seed, Jul 9, 2013, $3M — MPM BioImpact
- Series A, Jun 27, 2013, $7.7M — MPM BioImpact

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A, Seed
- TT Capital Partners — Series B
- Frist Cressey Ventures (https://capitalatlas.ai/funds/frist-cressey-ventures) — Series B
- QHP Capital (https://capitalatlas.ai/funds/qhp-capital) — Series B